Corcept Announces Presentation of Positive Results From Randomized, Controlled, Phase 2 Trial of Relacorilant in Patients With Recurrent Platinum-Resistant Ovarian Cancer at ESMO 2021

Matthew Durham
Omnidynamic Marketing

David Linetsky
Point-of-Care Marketing

Stacey Gandler
Brand Nourishment

Pat Purcell
Meeting Engagement

Brenda Snow
Authentic Patient Voice

Matt Turner
Patient Affordability

Frank Burrell
Scientific Storytelling

Daniel Sontupe
Market Access

Suma Ramadas, PhD
Medical Affairs

Paul Theisen
Patient Acquisition

Liz Kane
Impactful Strategy

Bud Bilanich
Success Coach

Amy Giles
Increasing Engagement

Joey Cohen
Medication Adherence